Related Experiment Video
Updated: Jul 3, 2026
12:32
High-resolution Respirometry to Measure Mitochondrial Function of Intact Beta Cells in the Presence of Natural Compounds
Published on: January 23, 2018
Mitochondrial dysfunction in pancreatic beta-cells in Type 2 diabetes.
Hindrik Mulder1, Charlotte Ling
1Department of Clinical Sciences in Malmö, Unit of Molecular Metabolism, Lund University Diabetes Centre, Clinical Research Center, Malmö University Hospital, Lund University, SE-205 02 Malmö, Sweden. hindrik.mulder@med.lu.se
Molecular and Cellular Endocrinology
|July 9, 2008
Summary
Mitochondrial dysfunction in pancreatic beta-cells contributes to Type 2 Diabetes by impairing insulin secretion. Understanding these mitochondrial changes offers potential therapeutic targets for diabetes.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Cellular Biology
Background:
- Insulin secretion by pancreatic beta-cells is regulated by mitochondrial metabolism.
- Type 2 Diabetes (T2D) is characterized by impaired insulin release and hyperglycemia.
- Genetic mitochondrial dysfunction can mimic T2D, suggesting a role in the disease.
Purpose of the Study:
- To review current knowledge on mitochondrial dysfunction in beta-cells in Type 2 Diabetes.
- To emphasize human observations while including relevant animal model studies.
- To explore changes in beta-cell mitochondrial metabolic enzymes, function, and structure.
Main Methods:
- Review of human studies and animal models of Type 2 Diabetes.
- Focus on alterations in beta-cell mitochondrial metabolic enzymes.
- Analysis of structural changes in mitochondria and their functional implications.
Main Results:
- Mitochondrial dysfunction is implicated in the pathogenesis of Type 2 Diabetes.
- Changes in metabolic enzymes and altered mitochondrial structure are observed in beta-cells.
- Genetic and epigenetic factors influence these mitochondrial alterations.
Conclusions:
- Alterations in beta-cell mitochondria are a potential cause of Type 2 Diabetes.
- These mitochondrial pathogenetic processes may represent novel therapeutic targets.
- Further research into mitochondrial dysfunction could lead to new diabetes treatments.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:36Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
01:20Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
01:21Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...